Capstone Investment Advisors
TNDM icon

Capstone Investment Advisors’s Tandem Diabetes Care TNDM Stock Holding History

Capstone Investment Advisors’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-13,585
Closed -$481K – 2473
2024
Q1 		$481K Buy
13,585
+5,288
+64% +$142K ﹤0.01% 1584
2023
Q4 		$245K Buy
+8,297
New +$172K ﹤0.01% 1693

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Capstone Investment Advisors's TNDM Position: Q2 2024 in Review

Capstone Investment Advisors sold out of Tandem Diabetes Care (TNDM) in Q2 2024, closing a stake of 13,585 shares — an estimated $481K sold.

Capstone Investment Advisors first reported a position in TNDM in Q4 2023 and held it in 2 quarters. The position peaked at $481K in Q1 2024. 317 funds tracked by Wall St. Rank hold TNDM as of Q2 2024.

  • Capstone Investment Advisors reported no remaining Tandem Diabetes Care position as of Q2 2024 after selling out during the quarter.
  • Capstone Investment Advisors sold 13,585 Tandem Diabetes Care shares in Q2 2024, an estimated $481K.
  • Capstone Investment Advisors first reported a position in Tandem Diabetes Care in Q4 2023 and held it in 2 quarters.
  • Capstone Investment Advisors's Tandem Diabetes Care position peaked at $481K in Q1 2024.
  • 317 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2024.

Based on Capstone Investment Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.